Comparing the vulnerable plaque group with the stable plaque group, there were no statistically significant differences in gender, age, BMI, smoking, history of hypertension, history of diabetes, history of stroke, albumin, glucose, triglycerides, total cholesterol, H-cholesterol, L-cholesterol, Apo AI, Apo B, C-reactive protein, hemoglobin, procalcitonin, D-dimer, FT3, and FT4 (p > 0.05). This evidence concerns the gene ALB and hypertensive disorder.